Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Ayumi, Numata"'
Autor:
Jun Nukui, Takayoshi Tachibana, Takuya Miyazaki, Masatsugu Tanaka, Kenji Matsumoto, Yoshimi Ishii, Ayumi Numata, Yuki Nakajima, Ayako Matsumura, Taisei Suzuki, Akihiko Izumi, Natsuki Hirose, Koji Yamamoto, Maki Hagihara, Shin Fujisawa, Hideaki Nakajima
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
Objectives Our previous study showed that a high pre-transplant nucleated cell count in the bone marrow is associated with increased non-relapse mortality (NRM) and decreased overall survival (OS) in patients with acute lymphoblastic leukemia (ALL) i
Externí odkaz:
https://doaj.org/article/cbbd33aabd284c38a0e4d611c81d16c1
Autor:
Ayako Matsumura, Takuya Miyazaki, Takayoshi Tachibana, Taiki Ando, Megumi Koyama, Satoshi Koyama, Yoshimi Ishii, Hiroyuki Takahashi, Yuki Nakajima, Ayumi Numata, Wataru Yamamoto, Kenji Motohashi, Maki Hagihara, Kenji Matsumoto, Shin Fujisawa, Hideaki Nakajima
Publikováno v:
Turkish Journal of Hematology, Vol 37, Iss 1, Pp 20-29 (2020)
Objective: A soluble form of suppression of tumorigenicity 2 (sST2) has emerged as a biomarker for acute graft-versus-host disease (GVHD) and non-relapse mortality (NRM). We prospectively monitored sST2 levels during the early phase of hematopoietic
Externí odkaz:
https://doaj.org/article/4b4bc0a7ebd54f418fa3fe9dadeb5d10
Autor:
Kenji Matsumoto, Shin Fujisawa, Taiki Ando, Megumi Koyama, Satoshi Koyama, Yoshimi Ishii, Ayumi Numata, Wataru Yamamoto, Kenji Motohashi, Maki Hagihara, Hideaki Nakajima
Publikováno v:
Turkish Journal of Hematology, Vol 35, Iss 3, Pp 181-184 (2018)
Objective: Useful prognostic biomarkers for diffuse large B-cell lymphoma (DLBCL) patients have been reported. To determine the prognostic value of hemoglobin (Hb) level in DLBCL patients, we performed a retrospective study. Materials and Methods: We
Externí odkaz:
https://doaj.org/article/61caa6ee9ca54c87b71870e6bdee68b9
Publikováno v:
Higher Brain Function Research. 42:301-309
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24a1f26c11a73dcc8c4fd3b65b80f847
https://doi.org/10.2496/hbfr.42.301
https://doi.org/10.2496/hbfr.42.301
Autor:
Yuki Nakajima, Ayako Matsumura, Maki Hagihara, Hideaki Nakajima, Megumi Koyama, Hiroyuki Takahashi, Kenji Matsumoto, Wataru Yamamoto, Taiki Ando, Takuya Miyazaki, Shin Fujisawa, Ayumi Numata, Satoshi Koyama, Kenji Motohashi, Yoshimi Ishii, Takayoshi Tachibana
Publikováno v:
Turkish Journal of Hematology
Turkish Journal of Hematology, Vol 37, Iss 1, Pp 20-29 (2020)
Turkish Journal of Hematology, Vol 37, Iss 1, Pp 20-29 (2020)
A soluble form of suppression of tumorigenicity 2 (sST2) has emerged as a biomarker for acute graft-versus-host disease (GVHD) and non-relapse mortality (NRM). We prospectively monitored sST2 levels during the early phase of hematopoietic stem cell t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14cd38403ed25f0e56433d10e485ddcc
http://europepmc.org/articles/PMC7057758
http://europepmc.org/articles/PMC7057758
Autor:
Masatsugu Tanaka, Eriko Ogusa, Taisei Suzuki, Heiwa Kanamori, Satoshi Koyama, Takayoshi Tachibana, Yasufumi Ishiyama, Taiki Ando, Hideaki Nakajima, Kenji Matsumoto, Ayumi Numata
Publikováno v:
Blood Advances. 4:408-419
We evaluated the kinetics of immune reconstitution (IR) after allogeneic hematopoietic cell transplantation (HSCT) and analyzed the clinical effect of IR on posttransplant outcomes. Absolute lymphocyte and its subset counts were measured using flow c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35d6151719123f78ecb75db5fb9e623b
https://doi.org/10.1182/bloodadvances.2019001021
https://doi.org/10.1182/bloodadvances.2019001021
Autor:
Heiwa Kanamori, Maki Hagihara, Hideki Nakasone, Aiko Igarashi, Masako Toyosaki, Makoto Onizuka, Rika Sakai, Noriko Doki, Ayumi Numata, Reiko Watanabe, Takeshi Kobayashi, Jun Kato, Takayoshi Tachibana, Takeshi Saito, Yuya Koda, Seiko Kato, Yoshinobu Kanda, Chikako Ohwada, Yuki Nakajima, Satoshi Koyama, Shin Fujisawa, Chiaki Nakaseko, Yasuyuki Aoyama, Masatsugu Tanaka, Emiko Sakaida, Katsuhiro Shono, Hiroaki Shimizu, Shinichiro Okamoto, Takehiko Mori
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:162-170
To prospectively validate the incidence, manifestations, and outcomes of graft-versus-host disease (GVHD) by National Institutes of Health criteria, we recruited 406 hematopoietic stem cell transplantation recipients at 16 transplant centers in Japan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f5a315ed04faebf2b96388df8e73c47
https://doi.org/10.1016/j.bbmt.2019.09.016
https://doi.org/10.1016/j.bbmt.2019.09.016
Autor:
Kazuho Miyashita, Ayumi Numata, Jun Taguchi, Hideyuki Koharazawa, Takayuki Sakuma, Yoshimi Ishii, Rika Sakai, Yuki Nakajima, Katsumichi Fujimaki, Takuya Miyazaki, Hideaki Nakajima, Hiroyuki Takahashi, Hiroyuki Fujita, Yukako Hattori, Chizuko Hashimoto, Ayako Matsumura, Sachiya Takemura
Publikováno v:
Indian J Hematol Blood Transfus
We performed a retrospective analysis of DLBCL with breast involvement to compare the prognosis of primary breast lymphoma (PBL) to secondary breast lymphoma (SBL; especially in limited stage cases). We retrospectively reviewed records of 25 diffuse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fc2154c6efe519ac72883e2ed113a8b
https://pubmed.ncbi.nlm.nih.gov/33707836
https://pubmed.ncbi.nlm.nih.gov/33707836
Autor:
Rumiko Okamoto, Kazutaka Sunami, Rishu Takimoto, Yukiyoshi Moriuchi, Kayoko Murayama, Ayumi Numata, Reina Watanabe, Masahiro Yokoyama, Yutaka Shimazu, Hirohiko Shibayama, Yasufumi Masaki, Kazuya Sato, Naoto Tomita, Masahide Yamamoto, Takahiro Yano, Hiromichi Takahashi, Ako Kikuchi, Kengo Takeuchi, Ikuo Miura, Chizuko Hashimoto, Wataru Yamamoto, Kazuo Tamura, Saburo Tsunoda, Rika Ohshima, Hideaki Nakajima, Tomohiro Kinoshita
Publikováno v:
Leukemia & Lymphoma. 59:97-104
Central nervous system (CNS) involvement is a serious complication in patients with diffuse large B-cell lymphoma (DLBCL) and evaluating CNS risk is an important issue. Using the standard international prognostic index (IPI) and CNS-IPI, a recently p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c198e85238556f8e28e3526cbe6fb3f7
https://doi.org/10.1080/10428194.2017.1330541
https://doi.org/10.1080/10428194.2017.1330541
Autor:
Rika Sakai, Masaki Suzuki, Atsushi Muroi, Yohei Miyagi, Hirotaka Takasaki, Ayumi Numata, Masanori Nojima, Naohiko Koshikawa, Tomoyuki Yokose
Publikováno v:
Proteomics. Clinical applications. 14(1)
Purpose Diffuse large B-cell lymphoma (DLBCL), the most common non-Hodgkin lymphoma, is a heterogeneous lymphoma with different clinical manifestations and molecular alterations, and several markers are currently being measured routinely for its diag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a294899494be15bad49fc3f06128e6c1
https://pubmed.ncbi.nlm.nih.gov/32109350
https://pubmed.ncbi.nlm.nih.gov/32109350